Latest AI Stock Forecasts - All Predictions

Signal date 2026-10-16 Cut-offs from the 2026-10-16 run

Companies scored 2758 IC ≥ 0 · market cap ≥ $100M

Median forecast +0.74% Total · 30D

Long–short spread +2.79% Strong Buy minus Strong Sell, mean

Median IC 0.17 Spearman · 30D

Rating changes ▲ 239 ▼ 400 vs the previous run

Cross-section

Distribution of the day's forecasts

30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

-1.3% 0 +3.6%

Signals · All

296 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

#	Ticker	Sector	IC	Mkt cap	Rating	30D	90D	Δ
1	LLYELI LILLY & Co	Life Sciences	-0.02	$1.2T	Unlock rating and forecasts
2	JNJJOHNSON & JOHNSON	Life Sciences	0.12	$615.9B	Unlock rating and forecasts
3	ABBVAbbVie Inc.	Life Sciences	0.01	$504.4B	Unlock rating and forecasts
4	MRKMerck & Co., Inc.	Life Sciences	0.15	$360.1B	Neutral	+0.85%	+2.37%	▲ 1
5	AZNASTRAZENECA PLC	Life Sciences	0.09	$256.4B	Unlock rating and forecasts
6	AMGNAMGEN INC	Life Sciences	-0.09	$233.8B	Unlock rating and forecasts
7	GILDGILEAD SCIENCES, INC.	Life Sciences	0.07	$193.7B	Unlock rating and forecasts
8	ABTABBOTT LABORATORIES	Life Sciences	0.00	$182.4B	Unlock rating and forecasts
9	NVONOVO NORDISK A S	Life Sciences	-0.03	$172.6B	Unlock rating and forecasts
10	PFEPFIZER INC	Life Sciences	0.35	$168.6B	Unlock rating and forecasts
11	VRTXVERTEX PHARMACEUTICALS INC / MA	Life Sciences	-0.05	$126.7B	Neutral	+0.52%	+1.84%	·
12	BMYBRISTOL MYERS SQUIBB CO	Life Sciences	0.34	$122.1B	Unlock rating and forecasts
13	GSKGSK plc	Life Sciences	-0.02	$100.5B	Unlock rating and forecasts
14	SNYSanofi	Life Sciences	0.28	$100.1B	Unlock rating and forecasts
15	MRNAModerna, Inc.	Life Sciences	0.53	$87.0B	Unlock rating and forecasts
16	REGNREGENERON PHARMACEUTICALS, INC.	Life Sciences	0.07	$81.8B	Unlock rating and forecasts
17	ARGXARGENX SE	Life Sciences	0.11	$50.7B	Unlock rating and forecasts
18	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD	Life Sciences	0.13	$48.4B	Unlock rating and forecasts
19	IDXXIDEXX LABORATORIES INC /DE	Life Sciences	0.15	$44.1B	Unlock rating and forecasts
20	ONCBeOne Medicines Ltd.	Life Sciences	0.14	$42.0B	Unlock rating and forecasts
21	RVMDRevolution Medicines, Inc.	Life Sciences	0.09	$38.1B	Unlock rating and forecasts
22	BIIBBIOGEN INC.	Life Sciences	0.36	$34.1B	Unlock rating and forecasts
23	ZTSZoetis Inc.	Life Sciences	0.34	$32.8B	Unlock rating and forecasts
24	ALNYALNYLAM PHARMACEUTICALS, INC.	Life Sciences	0.32	$31.0B	Neutral	+0.71%	+2.21%	·
25	RPRXRoyalty Pharma plc	Life Sciences	0.20	$26.9B	Neutral	+0.55%	+1.82%	·
26	ROIVRoivant Sciences Ltd.	Life Sciences	0.13	$24.2B	Unlock rating and forecasts
27	GMABGENMAB A/S	Life Sciences	0.09	$23.8B	Neutral	+1.08%	+3.11%	·
28	UTHRUNITED THERAPEUTICS Corp	Life Sciences	0.27	$22.9B	Unlock rating and forecasts
29	BNTXBioNTech SE	Life Sciences	-0.09	$22.2B	Unlock rating and forecasts
30	VTRSViatris Inc	Life Sciences	0.35	$21.4B	Unlock rating and forecasts
31	INSMINSMED Inc	Life Sciences	0.17	$21.0B	Neutral	+0.78%	+2.37%	·
32	ASNDAscendis Pharma A/S	Life Sciences	0.13	$14.8B	Unlock rating and forecasts
33	HALOHALOZYME THERAPEUTICS, INC.	Life Sciences	0.12	$13.8B	Neutral	+0.76%	+2.34%	·
34	NBIXNEUROCRINE BIOSCIENCES INC	Life Sciences	-0.14	$13.8B	Unlock rating and forecasts
35	JAZZJazz Pharmaceuticals plc	Life Sciences	0.24	$13.6B	Unlock rating and forecasts
36	BBIOBridgeBio Pharma, Inc.	Life Sciences	0.21	$13.0B	Neutral	+0.93%	+2.87%	·
37	CORTCORCEPT THERAPEUTICS INC	Life Sciences	0.29	$11.9B	Unlock rating and forecasts
38	ELANElanco Animal Health Inc	Life Sciences	0.33	$11.8B	Neutral	+0.54%	+2.02%	▲ 1
39	SMMTSummit Therapeutics Inc.	Life Sciences	0.14	$11.7B	Unlock rating and forecasts
40	TECHBIO-TECHNE Corp	Life Sciences	0.29	$11.4B	Unlock rating and forecasts
41	BMRNBIOMARIN PHARMACEUTICAL INC	Life Sciences	0.16	$10.6B	Neutral	+0.56%	+1.92%	▲ 1
42	QGENQIAGEN N.V.	Life Sciences	0.00	$10.0B	Neutral	+0.76%	+2.32%	·
43	RGENREPLIGEN CORP	Life Sciences	0.54	$9.9B	Unlock rating and forecasts
44	IBRXImmunityBio, Inc.	Life Sciences	0.21	$9.7B	Unlock rating and forecasts
45	KRYSKrystal Biotech, Inc.	Life Sciences	-0.04	$9.4B	Neutral	+0.68%	+2.24%	·
46	CYTKCYTOKINETICS INC	Life Sciences	0.33	$8.6B	Unlock rating and forecasts
47	TGTXTG THERAPEUTICS, INC.	Life Sciences	0.16	$8.6B	Unlock rating and forecasts
48	TWSTTwist Bioscience Corp	Life Sciences	0.32	$8.3B	Unlock rating and forecasts
49	AXSMAxsome Therapeutics, Inc.	Life Sciences	0.06	$8.2B	Unlock rating and forecasts
50	ARWRARROWHEAD PHARMACEUTICALS, INC.	Life Sciences	0.19	$7.9B	Unlock rating and forecasts

Breadth

By sector

Median 30D forecast per sector. Click to filter.

Life Sciences296 +1.6% Finance or Crypto Assets48 +1.6% Technology381 +1.0% Manufacturing434 +0.7% Trade & Services356 +0.6% Energy & Transportation313 +0.6% Industrial Applications and Services290 +0.6% Finance395 +0.6% Real Estate & Construction233 +0.5% Crypto Assets12 -0.2%

Since the previous run

Rating changes

▲ 239▼ 400

Which companies were upgraded or downgraded is part of the paid plans.

Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account

Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-16) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.

Daily Signals

Distribution of the day's forecasts

296 companies

By sector

Rating changes

Unlock the full ranking

Intratio Assistant

Cookie Settings

Essential Cookies

Analytics Cookies

Daily Signals

Distribution of the day's forecasts

296 companies

By sector

Rating changes

Unlock the full ranking